Long-term follow-up of subthalamic nucleus stimulation in glucocerebrosidase-associated Parkinson's disease

Autor: Daniel Weiss, Christoph Meisner, Thomas Gasser, Rejko Krüger, Alireza Gharabaghi, Daniela Berg, Ann-Kathrin Hauser, Christian Plewnia, Rosa Klotz, Tobias Wächter, Kathrin Brockmann, Karin Srulijes, Sorin Breit, Sophia Reinbold, Claudia Schulte
Rok vydání: 2011
Předmět:
Zdroj: Journal of neurology 259(9), 1970-1972 (2012). doi:10.1007/s00415-012-6469-7
ISSN: 1432-1459
DOI: 10.1007/s00415-012-6469-7
Popis: Dear Sirs,Heterozygous mutations in the gene encoding the lyso-somal enzyme beta-glucocerebrosidase (GBA) are associ-ated with an increased susceptibility to Parkinson’s disease(PD) and dementia with Lewy body disease [1, 2] and somecases with phenotypes similar to multiple system atrophywere reported [3]. GBA mutation carriers generally presentwith an earlier age at onset and particularly severe motor[2, 5] and non-motor [6] genotype-phenotype relationsprobably reflecting the more pronounced neocortical Lewybody-type pathology in GBA-associated PD [4]. Therefore,these were predicted to show an unfavorable therapeuticoutcome from Deep-brain stimulation of the subthalamicnucleus (STN-DBS). Here, we provide the first quantitativedata on the therapeutic outcomes of GBA-associated PD inresponse to
Databáze: OpenAIRE